MD1003 ‘effective’ in Phase III trial
Posted: Wed Jun 01, 2016 1:36 am
Data from an extension phase of a Phase III clinical trial claims the biotin MD1003 showed effectiveness over time as a possible treatment of non-active, progressive multiple sclerosis (MS)...Read more - http://www.ms-uk.org/MSnews